When GlaxoSmithKline (GSK) exited Nigeria in late 2023, it left a major gap in the country’s pharmaceutical supply chain. Oneread more Mecure investors ride antibiotic boom after GSK’s exit
Related Articles
Don't miss out on breaking stories and in-depth articles.